381 related articles for article (PubMed ID: 27729735)
21. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
22. Molecular insights into cancer drug resistance from a proteomics perspective.
An Y; Zhou L; Huang Z; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2019 May; 16(5):413-429. PubMed ID: 30925852
[TBL] [Abstract][Full Text] [Related]
23. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Findeisen P; Neumaier M
Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
[TBL] [Abstract][Full Text] [Related]
24. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry.
Liang Y; Fang M; Li J; Liu CB; Rudd JA; Kung HF; Yew DT
Exp Mol Pathol; 2006 Oct; 81(2):176-80. PubMed ID: 16828742
[TBL] [Abstract][Full Text] [Related]
25. Mass spectrometry and protein analysis.
Domon B; Aebersold R
Science; 2006 Apr; 312(5771):212-7. PubMed ID: 16614208
[TBL] [Abstract][Full Text] [Related]
26. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
Melle C; Ernst G; Schimmel B; Bleul A; Kaufmann R; Hommann M; Richter KK; Daffner W; Settmacher U; Claussen U; von Eggeling F
J Proteome Res; 2005; 4(5):1799-804. PubMed ID: 16212435
[TBL] [Abstract][Full Text] [Related]
27. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
Bai Z; Ye Y; Liang B; Xu F; Zhang H; Zhang Y; Peng J; Shen D; Cui Z; Zhang Z; Wang S
Int J Oncol; 2011 Feb; 38(2):375-83. PubMed ID: 21165559
[TBL] [Abstract][Full Text] [Related]
28. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
29. Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells.
Wang H; Hanash S
Methods; 2015 Jun; 81():34-40. PubMed ID: 25794949
[TBL] [Abstract][Full Text] [Related]
30. Discovery of tumor markers for gastric cancer by proteomics.
Wu JY; Cheng CC; Wang JY; Wu DC; Hsieh JS; Lee SC; Wang WM
PLoS One; 2014; 9(1):e84158. PubMed ID: 24404153
[TBL] [Abstract][Full Text] [Related]
31. [Identification of biomarkers in the serum of the patients with poorly differentiated gastric cancer].
Li W; Liu BY; Li JF; Chen XH; Hao JH; Cai Q; Gu QL; Zhu ZG; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):253-6. PubMed ID: 16721691
[TBL] [Abstract][Full Text] [Related]
32. Status of mass spectrometry-based proteomics and metabolomics in basic and translational research.
Kelleher NL
Biochemistry; 2013 Jun; 52(22):3794-6. PubMed ID: 23614658
[No Abstract] [Full Text] [Related]
33. Quantify this! Report on a round table discussion on quantitative mass spectrometry in proteomics.
Quadroni M; Ducret A; Stöcklin R
Proteomics; 2004 Aug; 4(8):2211-5. PubMed ID: 15274113
[TBL] [Abstract][Full Text] [Related]
34. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
[TBL] [Abstract][Full Text] [Related]
35. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
36. Comparative proteomics of apoptosis initiation induced by 5-fluorouracil in human gastric cancer.
Chen CY; Jia JH; Zhang MX; Zhou YB; Zhang RM; Yu XP
Chin J Physiol; 2006 Feb; 49(1):31-8. PubMed ID: 16900703
[TBL] [Abstract][Full Text] [Related]
37. [Proteomic identification and comparison of differentiation-related proteins in gastric carcinoma cell lines].
Li Y; Tan BB; Fan LQ; Zhao Q; Song ZC; Wang D
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):179-84. PubMed ID: 20450584
[TBL] [Abstract][Full Text] [Related]
38. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
39. Review of a current role of mass spectrometry for proteome research.
Chen CH
Anal Chim Acta; 2008 Aug; 624(1):16-36. PubMed ID: 18706308
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Lysophosphatidylcholine Acyltransferase 1 and Concomitant Lipid Alterations in Gastric Cancer.
Uehara T; Kikuchi H; Miyazaki S; Iino I; Setoguchi T; Hiramatsu Y; Ohta M; Kamiya K; Morita Y; Tanaka H; Baba S; Hayasaka T; Setou M; Konno H
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S206-13. PubMed ID: 25752890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
